NGENLA (somatropin‑CTP)
Pediatric growth hormone deficiency
ApprovedCommercial
Key Facts
About Opko Biologis
Platform biotech delivering long‑acting bio‑better protein therapeutics through CTP and reversible PEGylation technologies.
View full company profileTherapeutic Areas
Other Pediatric growth hormone deficiency Drugs
| Drug | Company | Phase |
|---|---|---|
| NGENLA™ (somatrogon) | Opko Health | Market |
| Long-acting rhGH (New Formulations) | Changchun High-Tech Industry | Development |
| TransCon hGH (lonapegsomatropin) | Ascendis Pharma | Approved |